Magazine Article | June 1, 2023

Leading Aulos Bioscience's "Triumvirate" Model

Source: Life Science Leader

By Ben Comer, Chief Editor, Life Science Leader

During the peak COVID-19 danger days of late 2020, a VC firm headquartered in New York City and a platform antibody company in Israel conceived a California-based immuno-oncology drug developer named Aulos Bioscience.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader